The subsequent ROC analysis showed that the AUC value was greater than or equal to 0.7, suggesting that RARRES2 can serve as a predictor of GBM patient prognosis (1, 3, and 5 years) (Fig. 7B). Here, RARRES2 is linked to glioblastoma.